European Society of Cardiology


Home
About the ESC
Membership
Communities
Congresses
Education
Guidelines & Surveys
Journals
Initiatives
Welcome to the European Society of Cardiology. Our mission: to reduce the burden of cardiovascular disease in Europe
 

Session Details

Important aspects of percutaneous valve therapy
29 Aug 15:30 - 16:30 Aortic valve disease Moderated Posters Moderated Posters - Zone A
Chairpersons: Vasco GAMA RIBEIRO (Vila Nova De Gaia, PT), Christoph NABER (Essen, DE)

Presentations list

Time
 
FP Nr
 
Title
 
Speakers
 
Related documents
15:30P1081Early benefits of transcatheter aortic valve replacement on the severity of secondary mitral regurgitationClaudiu Ionut STOICESCU (Bucharest, RO)
15:35P1082Effectiveness and durability at two years with CoreValve transcatheter aortic valveGerhard SCHULER (Leipzig, DE)
15:40P1083In-hospital outcome of aortic regurgitation after transcatheter aortic valve implantation: results from the prospective multicentre german TAVI registryMohamed ABDEL-WAHAB (Bad Segeberg, DE)
15:45P1084Hemodynamic and clinical impact of percutaneous mitral repair using the mitral clip systemJoerg HAUSLEITER (Muenchen, DE)
15:50P1085Transapical aortic valve implantation after previous heart surgeryThorsten DREWS (Berlin, DE)
15:55P1086Safety and efficacy comparison between implanted and non-implanted patients in the TITAN trial using the CARILLON Mitral Contour System to treat functional mitral regurgitationUta C HOPPE (Salzburg, AT)
16:00P1087Failing aortic valve prosthesis treated by percutaneously implanted CoreValve prosthesisFelix WOITEK (Leipzig, DE)
16:05P1088Is redo Percutaneous Mitral balloon Valvuloplasty (PMV) indicated in patients with post-PMV mitral restenosis?Bassem JERBI (Sfax, TN)
16:10 Discussion.To Be Announced